CUV 0.71% $14.09 clinuvel pharmaceuticals limited

THE CLINUVEL SHARE BUYBACK, page-41

  1. 16,334 Posts.
    lightbulb Created with Sketch. 4381
    Not even planning on sticking around for the Investor Call this evening? Oh well, hope the other stock goes well for you.

    Clinuvel steadily and strongly moving ahead fundamentally and they’ve reiterated their “household name by 2026” target which I was quite happy to read. Think we’ve got a winner here, $15 is not at all a reasonable valuation given the fast growing EPS of now over 70c, the large cash balance of almost $200m and the size of the pipeline imo
 
watchlist Created with Sketch. Add CUV (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.